The FDA expanded the indication of eculizumab (Soliris) to include pediatric patients ages 6 and older with generalized ...

Multisystem inflammatory syndrome in children (MIS-C), a serious disorder that develops after SARS-CoV-2 infection, could ...

Scientists reveal that reactivation of Epstein-Barr virus (EBV), driven by TGFβ-induced immune suppression, is a key driver ...

The risk of developing MS and other demyelinating diseases is 3 times greater in individuals diagnosed with EBV-positive IM.

Certain immune cells in MS show abnormalities in activity and signs of reactions against the Epstein-Barr virus, a study says ...

New research reveals that Epstein-Barr virus reactivation, triggered by COVID, may cause MIS-C in children. MIS-C is a severe ...

Scientists from Sweden’s Karolinska Institutet have uncovered new clues about how the Epstein-Barr virus (EBV) might ...

Researchers at Charité – Universitätsmedizin Berlin and the Leibniz Institute German Rheumatism Research Center (DRFZ) now report in the journal Nature that in affected children, a previously existing ...

Natural killer cell deficiency should be considered in patients susceptible to herpes virus or papillomavirus with persistently decreased NK cell function.

Study finds antibodies that target Epstein-Barr virus proteins can also attack proteins in the brain, increasing the likelihood of MS.